Back to results
US 12,703,698 B2Granted
Inhibitors of interleukin-1 receptor-associated kinases 1 and 4
AssigneeUniversity of Rochester
InventorsMichael Becker, Rakesh Singh, Richard Moore, Laura Calvi
Life of this patent
Estimating the term…
Abstract
The present disclosure provides compounds that are inhibitors of interleukin-1 receptor-associated kinases 1 and 4 (IRAK1 and IRAK4) and their use in the treatment of medical disorders such as autoimmune disorders, cancer, and pain disorders.
Claims3
A compound selected from:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.